What is the appropriate treatment for a cough in a cannabis smoker?

Treatment of Cough in Cannabis Smokers

Primary Recommendation

The most effective treatment for cough in cannabis smokers is complete cessation of cannabis use, which leads to resolution of respiratory symptoms to levels similar to non-users within weeks to months. 1, 2

Evidence for Cannabis Cessation

• Frequent cannabis use is strongly associated with morning cough (OR 1.97), sputum production (OR 2.31), and wheeze (OR 1.55) in young adults. 2
• Reducing or quitting cannabis use leads to resolution of cough, sputum, and wheeze to levels comparable to non-users. 2
• Smoking cessation should always be encouraged for patients with chronic lung disease, including cannabis-induced chronic bronchitis, as it is accompanied by significant remission in cough symptoms. 1, 3

Symptomatic Treatment Algorithm

First-Line Non-Pharmacologic Approach

• Start with honey and lemon mixture as the simplest, cheapest first-line treatment with evidence of patient-reported benefit. 3, 4
• Voluntary cough suppression through central modulation may be sufficient to reduce cough frequency. 3

Second-Line Pharmacologic Treatment

If symptoms persist despite cessation counseling, dextromethorphan is the preferred pharmacological agent:

• Prescribe dextromethorphan 60 mg (not the subtherapeutic over-the-counter doses of 15-30 mg) for maximum cough suppression. 3, 4
• Dextromethorphan can be dosed every 6-8 hours, with a maximum daily dose of 120 mg. 4
• This agent has superior safety compared to codeine-based alternatives while maintaining equivalent efficacy. 3, 4

Alternative Options for Refractory Cases

• For nocturnal cough disrupting sleep, first-generation sedating antihistamines (e.g., diphenhydramine, chlorpheniramine) may be used due to their sedative properties. 3, 4
• Menthol (as crystals or proprietary capsules) provides acute, short-lived cough suppression when inhaled. 3, 4
• Inhaled ipratropium bromide is effective for cough suppression in patients with chronic bronchitis. 3

When to Escalate or Discontinue

• If cough does not improve within 3-5 days of dextromethorphan therapy, discontinue the antitussive and reassess for underlying pathology. 4
• Opioid-derived antitussives (pholcodine, hydrocodone, or dihydrocodeine—NOT codeine) should only be considered after non-opioid options have failed. 4

Critical Pitfalls to Avoid

Do Not Suppress Productive Cough

• Avoid cough suppression if the patient has productive cough with significant sputum, as cough serves a physiological clearance function. 4
• Cannabis smoking can cause acute eosinophilic pneumonia, diffuse alveolar hemorrhage, and acute respiratory distress syndrome—conditions requiring steroids, not antitussives. 5, 6, 7

Recognize Red Flags Requiring Immediate Evaluation

• Patients with cough plus increasing breathlessness, fever, malaise, purulent sputum, hemoptysis, or chest pain require assessment for pneumonia, acute lung injury, or other serious conditions before prescribing antitussives. 1, 3, 5
• Cannabis inhalation can cause acute lung injury presenting with tachycardia, tachypnea, bilateral infiltrates, and elevated white blood cell count—these patients require short-term steroids, not cough suppressants. 5

Avoid Ineffective or Harmful Agents

• Do NOT use codeine or pholcodine as they have no greater efficacy than dextromethorphan but carry significantly higher adverse effect profiles including drowsiness, constipation, nausea, and dependence risk. 1, 3, 4
• Do NOT prescribe guaifenesin (an expectorant) for dry cough, as it does not suppress cough and has no role in non-productive cough management. 3
• Do NOT use subtherapeutic doses of dextromethorphan (15-30 mg); the effective dose is 60 mg. 3, 4

Special Considerations for Cannabis Users

Chronic Bronchitis Management

• For patients with established chronic bronchitis from cannabis smoking, there is insufficient evidence to recommend routine use of antibiotics, bronchodilators, or mucolytics specifically for cough relief. 1
• Inhaled bronchodilators (short-acting β-agonists, ipratropium) and combined long-acting β-agonist plus inhaled corticosteroid may improve cough in chronic bronchitis, but cessation remains the primary intervention. 1

Acute Exacerbations

• If the patient presents with acute exacerbation (increased sputum volume, purulence, worsening dyspnea), treat with bronchodilators, antibiotics, and oral corticosteroids rather than cough suppressants. 1, 3
• Short-term oral corticosteroids (prednisone 30-40 mg daily for 5-10 days) are effective for acute exacerbations of chronic bronchitis. 3

Duration of Therapy

• Dextromethorphan should be used only for short-term symptomatic relief (3-5 days maximum) and is not intended for long-term daily use. 3, 4
• Re-evaluate after 3-5 days; if cough persists, investigate alternative causes rather than continuing antitussive therapy. 3, 4